It has been four years since the start of the COVID-19 pandemic. SARS-CoV-2 has yet to be eradicated and new variants are continuously emerging. Despite the extensive immunization programs, breakthrough infections (infection ...
Jan 19, 2024
1
57
Cytomegalovirus (CMV) is a pathogen that likes to lurk. Most adults already carry CMV, and they show no symptoms at all. The trouble comes when the virus infects a pregnant person for the first time and passes through the ...
Jan 19, 2024
0
19
After COVID vaccination, it usually takes weeks for our bodies to develop protective antibody responses. Imagine, however, a vaccine that speeds up the production of antibodies against SARS-CoV-2, the virus that spreads COVID-19.
Jan 17, 2024
0
36
Recent SARS-CoV-2 variants such as BA.4 and BA.5 developed abilities missing from the first omicron variants that allowed them to overcome humans' innate immunity, according to research from UCL.
Jan 16, 2024
0
39
People with long COVID have dysfunctional immune cells that show signs of chronic inflammation and faulty movement into organs, among other unusual activity, according to a new study by scientists at Gladstone Institutes ...
Jan 11, 2024
0
122
When mice lacking key adaptive immune cells were infected with SARS-CoV-2 virus, even though they are not able to clear the virus, they developed no symptoms, revealing that the body's own inflammatory immune response to ...
Jan 11, 2024
0
51
Researchers at Karolinska Institutet have shown that nasal drops with IgA antibodies can protect mice from SARS-CoV-2 infection. The results imply a new way to protect individuals at high risk from different variants of the ...
Jan 10, 2024
0
147
A new paper in Molecular Biology and Evolution finds that HIV populations in people with higher viral loads also have higher rates of viral recombination. In effect, the more HIV in the blood, the easier it is for the virus ...
Jan 10, 2024
0
41
A team of scientists, led by Duke-NUS Medical School, has discovered a potential intranasal vaccine candidate that provides improved, longer-lasting immunity against SARS-CoV-2 viruses compared to when given as an injection. ...
Jan 9, 2024
0
156
Injecting neuroblastoma tumors with Zika virus shrank or eliminated those tumors in studies with mice, suggesting that the virus could someday serve as an effective cancer therapy, according to a study led by Nemours Children's ...
Jan 9, 2024
0
37
